Skip to main content
. 2022 Nov 22;17:100501. doi: 10.1016/j.mtbio.2022.100501

Table 1.

Selected CaP phases of interest for biomedical applications [[21], [22], [23], [24], [25], [26]].

Ca/P Molar Ratio CaP phase Name Formula pH Stability Range Density (g/cm3)
0.5 MCPM (monobasic calcium phosphate monohydrate) Ca(H2PO4)2·H2O 0.0–2.0 2.22
1.0 DCPA (dicalcium phosphate anhydrous) CaHPO4 2.0–5.5 (>80 ​°C) 2.929
1.0 DCPD (dibasic calcium phosphate dehydrate) CaHPO4·2H2O 2.0–6.0 2.319
1.3 OCP (octa calcium phosphate) Ca8(HPO4)2(PO4)4·5H2O 5.5–7.0 2.673
1.5 TCP (tricalcium phosphate) Ca3(PO4)2 2.814
1.2–2.2 ACP (amorphous calcium phosphate) CaxHy(PO4)z·nH2O n ​= ​3–4.5 15%–20% H2O 5–12
1.5–1.67 CDHAp (calcium deficient hydroxyapatite) Ca10-x (HPO4) x (PO4)6-x (OH)2-x (0 ​< ​x ​< ​2) 6.5–9.5
1.67 HAp (Hydroxyapatite) Ca10(PO4)6(OH)2 9.5–12.0 3.155
2.0 TTCP (tetra calcium phosphate) Ca4(PO4)2O 3.056